Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405847 · ClinicalTrials.gov registry record · Phase 4
A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients
A Phase 4 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00405847 is a Phase 4 study that has completed, run by University of Arizona. The registered enrollment target is 17 participants.
The verdict
NCT00405847, a Phase 4 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the short-term effect of sympatholysis on sleep quality and inflammation in critically ill patients.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00405847
The ClinicalTrials.gov registry entry for NCT00405847 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT00405847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00405847 about?
NCT00405847 is a clinical study titled "A Pilot Study of Effect of Dexmedetomidine on Sleep and Inflammation in Critically Ill Patients". The purpose of this study is to assess the short-term effect of sympatholysis on sleep quality and inflammation in critically ill patients.
What is the current status of trial NCT00405847?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2006-07. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00405847?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00405847?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.